Paper Details

  1. Home
  2. Paper Details

Betaxolol and timolol. A comparison of efficacy and side effects.

Author: BerryD P, ShieldsM B, Van BuskirkE M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Betaxolol and timolol were comparable in efficacy and side effects for treatment of open-angle glaucoma.
Paper Details　
Original Abstract of the Article :
Betaxolol hydrochloride, 0.5%, and timolol maleate, 0.5%, were compared in a 26-week randomized, double-masked study involving 46 patients with primary open-angle glaucoma. The two drugs were comparable with regard to both intraocular pressure-lowering efficacy and side effects. Since betaxolol is a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1001/archopht.1984.01040030026028

データ提供：米国国立医学図書館（NLM）

Betaxolol vs. Timolol: Navigating the Sands of Glaucoma Treatment

Glaucoma, a condition that can lead to irreversible vision loss, can feel like a blinding sandstorm, obscuring the world around us. This research, a careful comparison of two commonly used glaucoma medications—betaxolol and timolol—offers valuable insights for clinicians seeking to optimize treatment strategies for their patients. The researchers conducted a randomized, double-masked study, comparing the efficacy and safety of betaxolol and timolol in patients with primary open-angle glaucoma. Their findings suggest that both medications are effective in lowering intraocular pressure, but betaxolol, with its selective beta 1-adrenergic antagonist properties, may offer a safer option for certain patients.

Finding the Right Medication for Glaucoma

This research underscores the importance of finding the right medication for each individual patient with glaucoma. Just as a camel needs to be chosen carefully based on the terrain and the length of the journey, glaucoma medications need to be selected based on the patient's specific needs and risk factors. The researchers' findings highlight the need for personalized glaucoma care, considering the individual characteristics of each patient.

Glaucoma: A Silent Thief of Sight

This research reminds us that glaucoma is a silent thief of sight, often progressing without noticeable symptoms in its early stages. Regular eye exams, like scouting the desert for potential hazards, are crucial for early detection and treatment of glaucoma. Early intervention can significantly improve outcomes and reduce the risk of vision loss.

Dr.Camel's Conclusion

This study offers valuable insights into the efficacy and safety of betaxolol and timolol in treating primary open-angle glaucoma. The findings suggest that both medications are effective in lowering intraocular pressure, but betaxolol, with its selective beta 1-adrenergic antagonist properties, may offer a safer option for certain patients. The study emphasizes the importance of personalized glaucoma care and regular eye exams for early detection and treatment of this potentially blinding condition.

Date :
  1. Date Completed 1984-04-24
  2. Date Revised 2019-07-04
Further Info :

Pubmed ID

6367723

DOI: Digital Object Identifier

10.1001/archopht.1984.01040030026028

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.